The company plans to offer testosterone replacement therapy, marking its first foray into prescribing controlled substances.
Related stories
Foursquare co-founder says equity holders saw no returns from the company’s acquisition
AI Guardrails Aren’t Stopping Criminal Hackers
AI promises productivity, but for managers, it’s mostly a headache for now
Our Favorite Darn Tough Merino Wool Socks Are on Sale at REI
Heat pump tech is 170 years old. Pascal thinks it’s time for an update.
Roku Pro Series OLED TV Review (2026)